Stocks

Cannae Holdings Now Owns 29.70% of System1 Group (SST)

Fintel reports that Cannae Holdings has filed a 13D/A form with ...

JP Morgan Downgrades Crestwood Equity Partners (CEQP)

On March 14, 2023, JP Morgan downgraded their outlook for C...

Vertical Research Downgrades Univar (UNVR)

On March 14, 2023, Vertical Research downgraded their outlo...

Chinese consumers out of COVID gates with caution, rath...

Chinese consumers, unshackled from COVID-19 restrictions, are returning to hotel...

Keybanc Upgrades Avid Bioservices (CDMO)

On March 14, 2023, Keybanc upgraded their outlook for Avid ...

Tang Capital Partners Now Owns 10.20% of Jounce Therape...

Fintel reports that Tang Capital Partners has filed a 13D form w...

JonesTrading Initiates Coverage of Trevi Therapeutics (...

On March 14, 2023, JonesTrading initiated coverage of Trevi ...

Vacasa, Inc. (VCSA) Q4 Earnings and Revenues Beat Estim...

Vacasa, Inc. (VCSA) came out with quarterly earnings of $0.35 per share, beating...

Find Strong Stocks to Buy in March with New Analyst Cov...

Stocks rebounded in a big way on Tuesday as Wall Street appears to breathe a sig...

Custom Truck One Source, Inc. (CTOS) Q4 Earnings and Re...

Custom Truck One Source, Inc. (CTOS) came out with quarterly earnings of $0.15 p...

Dow Breaks 5-Day Losing Streak as Investors Come to Terms

The Dow managed to snap a five-day losing streak on an up-session for the market...

Casa Systems (CASA) Q4 Earnings and Revenues Beat Estim...

Casa Systems (CASA) came out with quarterly earnings of $0.05 per share, beating...

Oceaneering International (OII) Gains But Lags Market: ...

In the latest trading session, Oceaneering International (OII) closed at $18.09,...

Chubb (CB) Gains But Lags Market: What You Should Know

In the latest trading session, Chubb (CB) closed at $194.01, marking a +1.06% mo...

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gai...

CRISPR Therapeutics AG (CRSP) closed at $45.15 in the latest trading session, ma...

This information is not an offer to buy, sell, or hold any cryptocurrency. Individuals who may copy within the CopyTrader Program are not deemed investment advisors and their performances in the past are not indicative of future results. All investment and copy trading carries risk and you should do your due diligence before investing.